Regional Disparities in the Uptake
of Differentiated Influenza
Vaccines
Salaheddin M. Mahmud MD PhD1,*, Gurpreet Pabla
BSc1, Christiaan H. Righolt PhD1,
Geng Zhang, MSc1, Matthew M. Loiacono
PhD2, Edward Thommes PhD3 4, Heidi
Kabler MD5 6 7, Ayman Chit PhD8 9
1 Vaccine and Drug Evaluation Centre, Department of
Community Health Sciences, University of Manitoba, 337–750 McDermot
Avenue, Winnipeg, MB, R3E 0T5 Canada
2 Global Medical Evidence Generation, Sanofi, 1
Discovery Dr, 18370, Swiftwater, PA, United States
3 Global Modeling Epidemiology and Data Science,
Sanofi, 1755 Steeles Ave W, North York, ON M2R 3T4, Canada
4 Department of Mathematics & Statistics, University
of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1, Canada
5 US Medical Affairs, Sanofi, 1 Discovery Dr, 18370,
Swiftwater, PA United States
6 MountainView Program in Emergency Medicine,
MountainView Hospital, 3100 N Tenaya Way, 89128, Las Vegas, NV United
States
7 Reno School of Medicine, University of Nevada, Reno,
89557, NV, United States
8 Global Medical, Sanofi, 14 Espa. Henry Vallée, 69007
Lyon, France
9 Leslie Dan Faculty of Pharmacy, University of
Toronto, Toronto, Ontario, Canada
*Address for correspondence:
Dr. Salaheddin Mahmud, MD PhD FRCPC
Professor and Director, Vaccine and Drug Evaluation Centre, Department
of Community Health Sciences, University of Manitoba,
337 - 750 McDermot Avenue, Winnipeg, Manitoba, R3E 0T5 Canada
Salah.Mahmud@gmail.com
Keywords: influenza; seasonal influenza vaccine; high-dose influenza
vaccine; inequities; disparities; Enhanced influenza vaccines.
FUNDING STATEMENT
This collaborative study with the University of Manitoba was funded by
Sanofi (US).
ETHICS APPROVAL STATEMENT
The University of Manitoba
Research Ethics Board approved this study.
CONFLICTS OF INTEREST
DISCLOSURE
SMM received research funding from Assurex, GSK, Merck, Pfizer, Roche
and Sanofi for unrelated studies and is/was a member of advisory boards
for GSK, Merck, Sanofi and Seqirus. CHR has received an unrestricted
research grant from Pfizer for an unrelated study. MML, ET, HK, and AC
are employees of Sanofi and may hold shares and/or stock options in the
company.
AUTHOR CONTRIBUTIONS
Salaheddin Mahmud : Conceptualization, Methodology, Formal
analysis, Investigation, Resources, Writing - Original Draft,
Visualization, Supervision, Funding acquisition; Gurpreet Pabla
BSc: Software, Formal analysis, Investigation, Data Curation, Writing -
Review & Editing, Visualization; Christiaan Righolt :
Methodology, Validation, Investigation, Writing - Review & Editing,
Project administration; Geng Zhang MSc : Software, Data
Curation, Writing - Review & Editing, Visualization; Matthew M.
Loiacono : Investigation, Resources, Data Curation, Writing - Review &
Editing, Project administration; Heidi Kabler :
Conceptualization, Investigation, Writing - Review & Editing, Funding
acquisition; Edward Thommes : Conceptualization, Investigation,
Writing - Review & Editing, Funding acquisition; Ayman Chit :
Conceptualization, Investigation, Writing - Review & Editing, Funding
acquisition
DATA AVAILABILITY
STATEMENT
Data used in this article was derived from administrative health and
social data as a secondary use. The data was provided under specific
data sharing agreements only for approved use. The original source data
is not owned by the researchers and as such cannot be provided to a
public repository. Source data specific to this article may be accessed
with the consent of the data provider, along with the required privacy
and ethical review bodies.